Re: Exempt Distribution
in response to
by
posted on
Mar 16, 2020 07:05PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Interesting the price converts to 3.72 can per unit.say 30cents half a wt leaves 3.42 a share